Business Description
Jin Yang Pharmaceutical Co Ltd
ISIN : KR7007370000
Compare
Compare
Traded in other countries / regions
007370.Korea IPO Date
2000-07-27Description
Jin Yang Pharmaceutical Co Ltd is a drug manufacturer in South Korea. The products of the company are bonid, carnit, livera, ganatiran, megaton, and magtin.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.1 | |||||
| Equity-to-Asset | 0.75 | |||||
| Debt-to-Equity | 0.09 | |||||
| Debt-to-EBITDA | 0.47 | |||||
| Interest Coverage | 6.61 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 3.3 | |||||
| Beneish M-Score | -2.17 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 25.4 | |||||
| 3-Year EBITDA Growth Rate | 25.4 | |||||
| 3-Year EPS without NRI Growth Rate | 39.7 | |||||
| 3-Year FCF Growth Rate | 14.2 | |||||
| 3-Year Book Growth Rate | 24.4 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 37.91 | |||||
| 9-Day RSI | 36.44 | |||||
| 14-Day RSI | 35.82 | |||||
| 6-1 Month Momentum % | -6.19 | |||||
| 12-1 Month Momentum % | -5.26 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.96 | |||||
| Quick Ratio | 1.25 | |||||
| Cash Ratio | 0.35 | |||||
| Days Inventory | 173.36 | |||||
| Days Sales Outstanding | 84.01 | |||||
| Days Payable | 30.73 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 2.76 | |||||
| Dividend Payout Ratio | 0.15 | |||||
| 3-Year Dividend Growth Rate | 14.5 | |||||
| Forward Dividend Yield % | 2.76 | |||||
| 5-Year Yield-on-Cost % | 4.35 | |||||
| 3-Year Average Share Buyback Ratio | 1.2 | |||||
| Shareholder Yield % | 2.03 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 61.06 | |||||
| Operating Margin % | 9.65 | |||||
| Net Margin % | 13.45 | |||||
| FCF Margin % | 7.44 | |||||
| ROE % | 15.25 | |||||
| ROA % | 10.59 | |||||
| ROIC % | 8.93 | |||||
| ROC (Joel Greenblatt) % | 22.48 | |||||
| ROCE % | 15.7 | |||||
| Years of Profitability over Past 10-Year | 7 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 5.38 | |||||
| PE Ratio without NRI | 5.54 | |||||
| Shiller PE Ratio | 24.95 | |||||
| Price-to-Owner-Earnings | 9.02 | |||||
| PEG Ratio | 0.14 | |||||
| PS Ratio | 0.72 | |||||
| PB Ratio | 0.66 | |||||
| Price-to-Tangible-Book | 0.71 | |||||
| Price-to-Free-Cash-Flow | 9.94 | |||||
| Price-to-Operating-Cash-Flow | 8.3 | |||||
| EV-to-EBIT | 4.15 | |||||
| EV-to-EBITDA | 3.48 | |||||
| EV-to-Revenue | 0.62 | |||||
| EV-to-FCF | 8.33 | |||||
| Price-to-Projected-FCF | 0.52 | |||||
| Price-to-Median-PS-Value | 0.63 | |||||
| Price-to-Peter-Lynch-Fair-Value | 0.22 | |||||
| Price-to-Graham-Number | 0.42 | |||||
| Price-to-Net-Current-Asset-Value | 3.31 | |||||
| Earnings Yield (Greenblatt) % | 24.1 | |||||
| FCF Yield % | 11.94 | |||||
| Forward Rate of Return (Yacktman) % | 25.94 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Jin Yang Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 94,111.138 | ||
| EPS (TTM) (â‚©) | 1011 | ||
| Beta | 0.75 | ||
| Volatility % | 15.77 | ||
| 14-Day RSI | 35.82 | ||
| 14-Day ATR (â‚©) | 87.216546 | ||
| 20-Day SMA (â‚©) | 5502 | ||
| 12-1 Month Momentum % | -5.26 | ||
| 52-Week Range (â‚©) | 5350 - 6900 | ||
| Shares Outstanding (Mil) | 10.78 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Jin Yang Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Jin Yang Pharmaceutical Co Ltd Stock Events
| Event | Date | Price(â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
Jin Yang Pharmaceutical Co Ltd Frequently Asked Questions
What is Jin Yang Pharmaceutical Co Ltd(XKRX:007370)'s stock price today?
The current price of XKRX:007370 is â‚©5440.00. The 52 week high of XKRX:007370 is â‚©6900.00 and 52 week low is â‚©5350.00.
When is next earnings date of Jin Yang Pharmaceutical Co Ltd(XKRX:007370)?
The next earnings date of Jin Yang Pharmaceutical Co Ltd(XKRX:007370) is .
Does Jin Yang Pharmaceutical Co Ltd(XKRX:007370) pay dividends? If so, how much?
The Dividend Yield %  of Jin Yang Pharmaceutical Co Ltd(XKRX:007370) is 2.76% (As of Today), Highest Dividend Payout Ratio of Jin Yang Pharmaceutical Co Ltd(XKRX:007370) was 1.94. The lowest was 0.12. And the median was 0.23. The  Forward Dividend Yield % of Jin Yang Pharmaceutical Co Ltd(XKRX:007370) is 2.76%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers